Azelnidipine is an isopropyl ester. Azelnidipine is a dihydropyridine calcium channel blocker. It is marketed by Daiichi-Sankyo pharmaceuticals, Inc. in Japan. It has a gradual onset of action and produces a long-lasting decrease in blood pressure, with only a small increase in heart rate, unlike some other calcium channel blockers. It is currently being studied for post-ischemic stroke management. It is grouped under the following drug class(es): Calcium Channel Blockers and Vasodilating agents. Its therapeutic use is listed as antihypertensives and cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Calblock, Azelnidipino and azelnidipinum. Its PubChem CID is 65948.
Azelnidipine
| CAS No | 123524-52-7 |
|---|---|
| Molecular Formula | C33H34N4O6 |
| Molecular Weight | 582.64 g/mol |
| Synonyms | 3-O-(1-benzhydrylazetidin-3-yl) 5-O-propan-2-yl 2-amino-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Azelnidipine is an isopropyl ester. Azelnidipine is a dihydropyridine calcium channel blocker. It is marketed by Daiichi-Sankyo pharmaceuticals, Inc. in Japan.
The listed CAS number is 123524-52-7.
The listed molecular formula is C33H34N4O6.
The listed molecular weight is 582.64 g/mol.
3-O-(1-benzhydrylazetidin-3-yl) 5-O-propan-2-yl 2-amino-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.
The source lists Calblock, Azelnidipino and azelnidipinum.